Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB272440PCP

FAM84B Antibody (OTI1D12), PerCP, Novus Biologicals™
SDP

Catalog No. NB272440PCP Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB272440PCP 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB272440PCP Supplier Novus Biologicals Supplier No. NBP272440PCP
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

FAM84B Monoclonal specifically detects FAM84B in Human samples. It is validated for Flow Cytometry.

Specifications

Antigen FAM84B
Applications Flow Cytometry
Classification Monoclonal
Clone OTI1D12
Conjugate PerCP
Dilution Flow Cytometry
Formulation PBS with 0.05% Sodium Azide
Gene Alias BCMP101neurological/sensory 2, Breast cancer membrane protein 101, breast cancer membrane-associated protein 101, family with sequence similarity 84, member B, NSE2Protein NSE2
Gene Symbols FAM84B
Host Species Mouse
Immunogen Full length recombinant protein of human FAM84B (NP_777571) produced in HEK293T cells.
Purification Method Affinity Purified
Quantity 0.1 mL
Research Discipline Neuroscience
Primary or Secondary Primary
Gene ID (Entrez) 157638.0
Target Species Human
Content And Storage Store at 4°C in the dark.
Isotype IgG1
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.